Marley Ghizzone

Dogs are man’s best friend, but recent reports served as a reminder that they carry bacteria in their saliva that can cause disease, and even death, in humans. In June, a man in West Bend, Wisconsin, had both hands and lower legs amputated after being infected with the bacterium Capnocytophaga canimorsus, possibly through contact with a dog, according to the Milwaukee Journal Sentinel. Two

Data from seven recent influenza seasons in Canada showed the influenza vaccine may be more effective in females than males, according to study findings published in Open Forum Infectious Diseases.Between 2010-2011 and 2016-2017, overall vaccine effectiveness was 49% for females and 38% for males, according to Danuta Skowronski, MD, MHSc, FRCPC, physician epidemiologist at the BC Centre for

John O. Mascarenhas, MD, spoke with Healio about a presentation given during the morning session at 14th International Congress on Myeloproliferative Neoplasms. “Ann Mullally gave a terrific talk about mutant calreticulin,” Mascarenhas, professor of medicine at Icahn School of Medicine at Mount Sinai, director of Center of Excellence for Blood Cancer and Myeloid Disorders, and member of Tisch Cancer Institute, said.

In this video, Catherine Lai, MD, MPH, spoke with Healio about patients with newly diagnosed or relapsed acute myeloid leukemia who stopped treatment with azacitidine/venetoclax after receiving one or more cycles past remission. The findings about the azacitidine/venetoclax (Venclexta; Genentech, AbbVie) regimen were presented at ASH Annual Meeting and Exposition.

In this video, Akriti Jain, MD, discusses a new targeted monotherapy being used for patients with acute myeloid leukemia, tuspetinib. Results from the APTIVATE trials were presented at ASH Annual Meeting and Exposition.

In this video, Albert C. Yeh, MD, discusses use of chimeric antigen receptor T-cell therapy for autoimmune diseases, one of many topics covered at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. “That’s quite fascinating because there’s actually more cases of autoimmune diseases than there are cancer cases that are treatable with CAR T cells,” Yeh, physician and research associate of Translational Science and Therapeutics at Fred Hutch Cancer Center and acting assistant professor at the University of Washington School of Medicine, told Healio.